Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,710 | N/A | 11,490 | 12,190 | 320 |
| Receivables | 30 | N/A | 0 | 0 | 0 |
| Inventories | 0 | N/A | 0 | 0 | 340 |
| Other current assets | 10 | 10 | 60 | 20 | 170 |
| TOTAL | $2,750 | $10 | $11,550 | $12,210 | $830 |
| Non-Current Assets | |||||
| PPE Net | 1,050 | 1,440 | 2,060 | 290 | 220 |
| Other Non-Current Assets | 260 | 10 | 10 | 0 | 450 |
| TOTAL | $1,310 | $1,450 | $2,070 | $290 | $670 |
| Total Assets | $4,070 | $1,460 | $13,630 | $12,510 | $1,510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 1,000 |
| Accounts payable and accrued liabilities | 400 | 570 | 720 | 540 | 2,590 |
| Accrued Expenses | 9 | 40 | 50 | 180 | 440 |
| TOTAL | $420 | $610 | $1,680 | $720 | $5,020 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 0 | 0 | 8,500 |
| Other Non-Current Liabilities | 90 | 0 | 0 | 0 | 3,370 |
| TOTAL | $100 | $N/A | $N/A | $N/A | $11,870 |
| Total Liabilities | $530 | $610 | $1,680 | $720 | $16,900 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 40 | 290 |
| Retained earnings | -42,010 | N/A | -31,070 | -8,770 | -103,430 |
| Other shareholders' equity | -20 | 0 | -10 | 0 | 10 |
| TOTAL | $3,540 | $45,040 | $11,940 | $11,780 | $-15,380 |
| Total Liabilities And Equity | $4,070 | $45,650 | $13,620 | $12,500 | $1,520 |